ACR Insider Trading

Insider Ownership Percentage: 18.00%
Insider Buying (Last 12 Months): A$30,060.53
Insider Selling (Last 12 Months): A$0.00

Acrux Insider Trading History Chart

This chart shows the insider buying and selling history at Acrux by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acrux Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ACR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Acrux Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2024Ross DobinsonInsiderExercise418,851A$0.06A$23,036.81
12/20/2023Timothy OldhamInsiderBuy414,561A$0.05A$18,655.25
12/5/2023Geoffrey BrookeInsiderIssued1,062,946A$0.05A$52,084.35
11/24/2023Ross DobinsonInsiderExercise237,610A$0.04A$10,217.23
8/30/2023Ross DobinsonInsiderBuy237,610A$0.05A$11,405.28
6/16/2023Geoffrey BrookeInsiderExercise138,187A$0.05A$6,356.60
5/24/2023Ross DobinsonInsiderExercise237,610A$0.05A$10,930.06
3/31/2023Geoffrey BrookeInsiderBuy138,187A$0.06A$8,291.22
3/9/2023Donald BrumleyInsiderBuy1,455,000A$0.06A$91,665.00
3/1/2023Donald BrumleyInsiderExercise138,187A$0.06A$8,429.41
12/1/2022Ross DobinsonInsiderExercise81,950A$0.07A$5,900.40
11/25/2022Timothy OldhamInsiderIssued552,748A$0.07A$37,586.86
10/28/2022Geoffrey BrookeInsiderExercise614,721A$0.08A$50,407.12
8/30/2022Donald BrumleyInsiderExercise59,555A$0.06A$3,573.30
6/22/2022Timothy OldhamInsiderExercise646,110A$0.07A$42,643.26
5/23/2022Donald BrumleyInsiderBuy57,614A$0.07A$4,090.59
3/15/2022Donald BrumleyInsiderExercise171,546A$0.09A$15,267.59
11/29/2021Donald BrumleyInsiderBuy750,000A$0.12A$89,250.00
11/26/2021Donald BrumleyInsiderIssued347,624A$0.12A$42,062.50
9/15/2021Ross DobinsonInsiderExercise81,944A$0.14A$11,472.16
6/15/2021Ross DobinsonInsiderExercise81,944A$0.12A$9,423.56
See Full Table

SEC Filings (Institutional Ownership Changes) for Acrux (ASX:ACR)

12.22% of Acrux stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Acrux logo
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Read More on Acrux

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


4,000 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Acrux?

Acrux's top insider shareholders include:
  1. Donald Brumley (Insider)
  2. Geoffrey Brooke (Insider)
  3. Ross Dobinson (Insider)
  4. Timothy Oldham (Insider)
Learn More about top insider investors at Acrux.